@newsramp.comCreative Biolabs expands lipid-based delivery capabilities, offering targeted and stimuli-responsive liposome development to help researchers overcome stability, targeting, and controlled release challenges. #DrugDelivery #Liposomes
@coherentcmi.bsky.socialLarge Volume Parenteral Market: Size, Growth, and Regional Opportunities
www.coherentcmi.com/market-insig...
#IntravenousTherapy #InjectableDrugs #Pharmaceuticals #DrugDelivery #HospitalCare #MedicalSupplies #PharmaIndustry #HealthcareMarket #MarketResearch #GlobalMarket
@intjextremmanuf.bsky.socialLiving organisms could expand what miniature robots can achieve.
This review examines biohybrid miniature robots, from #Fabrication and driving mechanisms to applications in #DrugDelivery, disease treatment, sensing, and rescue.
@particle-metrix.bsky.socialWe’re ready for #CRS2026 in Lyon!
Our booth is set up, and we’re looking forward to two days of great science, new connections & discussions at the 3rd BeNeLux & France Local Chapter Meeting.
Stop by our booth and say hello to Bertrand Damart!
#LNPs #DrugDelivery #NTA #ZetaView #ParticleMetrix
@bio-integration.orgSmart ocular inserts, drug-loaded lenses, and microneedles deliver drugs with sustained release, improved retention, and high bioavailability, advancing patient comfort therapies. #medsky #Ophthalmology #DrugDelivery
#BIOI #OpenAccess: doi.org/10.15212/bio...
@otdc-2026.bsky.social⏰ The deadline is TODAY!
Register for OTDC 2027 and connect with advances in Oligonucleotide Therapeutics, RNA Technologies, Drug Delivery, CRISPR & Aptamer Technologies.
📅 May 11–12, 2027 | Boston + Hybrid
🔗 oligo-nucleotide.com
@sigtrans-sttt.bsky.socialTraditional #Biomarker discovery suffers from single-modality analyses, weak mechanistic foundations, and low reproducibility.
This review examines #AI approaches for precision diagnostics and targeted therapies.
@bio-integration.orgCan #Biomaterials solve cartilage #DrugDelivery?
This review highlights systems that penetrate cartilage, bind ECM, and sustain drug pools, advancing osteochondral regeneration. #Orthopedics @ucl.ac.uk #medsky
#BIOI #OpenAccess: doi.org/10.15212/bio...
@sigtrans-sttt.bsky.socialHow can functional RNA molecules move beyond simple protein coding to power next-gen loss- and gain-of-function treatments? This review explores emerging druggable RNAs, optimization, and delivery systems for #clinicaltherapeutics.
@mdpipharma.bsky.social
@otdc-2026.bsky.social🧬 From sequence to solution.
OTDC 2027 explores emerging advances in oligonucleotide therapeutics, RNA medicines, and innovative delivery technologies shaping the future of healthcare.
📅 May 11–12, 2027 | Boston, MA & Virtual
🔗 oligo-nucleotide.com
#OTDC2027 #RNA #DrugDelivery
@otdc-2026.bsky.social🧬 Small molecules. Bigger possibilities.
Explore the next wave of oligonucleotide therapeutics, RNA medicines, and innovative delivery technologies at OTDC 2027.
📅 May 11–12, 2027 | 📍 Boston, MA & Virtual
🔗 oligo-nucleotide.com
#OTDC2027 #RNA #Oligonucleotides #DrugDelivery
@otdc-2026.bsky.social“Targeted science for healthier futures.”
Discover emerging research across oligonucleotide therapeutics, RNA therapeutics, mRNA, and next-generation delivery at OTDC 2027.
May 11–12, 2027 | Boston, MA | In-Person & Virtual
🌐 oligo-nucleotide.com
@mdpipharma.bsky.social🏅 77 citations — #highly #cited! #Lipid #nanoparticles for #biologics—chemistry, manufacturing, characterization & scale-up. Covers #proteins, #nucleic #acids & #mRNA, plus opportunities & challenges.
⚗️ www.mdpi.com/1999-4923/16...
#LipidNanoparticles #Biologics #DrugDelivery
@in-armor.bsky.social🚀 This achievement strengthens the integration of nanotechnology, drug development and biological validation within the IN-ARMOR pipeline, supporting the progression of selected candidates towards preclinical evaluation.
@mdpipharma.bsky.social🤔 Can #oral insulin overcome GI degradation? This study uses #solid #lipid #nanoparticles from natural soaps via coacervation + hydrophobic ion pairing. Gut permeation enhanced; #spray-dried #powder enables solid forms!
📌 www.mdpi.com/1999-4923/17...
#OralInsulin #Nanoparticles #DrugDelivery
@otdc-2026.bsky.social🧬 From Nucleic Acids to Real-World Impact.
OTDC 2027 explores advances in oligonucleotide therapeutics, RNA medicines, and innovative delivery technologies.
📅 May 11–12, 2027 | 📍 Boston, MA & Virtual
🔗 oligo-nucleotide.com
#OTDC2027 #Oligonucleotides #RNATherapeutics #DrugDelivery
@faculty-o-pharmacy.bsky.socialVery Important Progress 🚀 The Faculty congratulates Mingjun Wu • Lidia Habtemikael • Ellen Brunzell and several other SweDeliver researchers on publishing new findings that contribute knowledge to research and current challenges in #drugdelivery 🍏 Learn more about these & more advances!
@materchemfront.rsc.org🔔 Review article by Liyan Yang and Zhonglei Wang
Podophyllotoxin-based intelligent nanoplatforms for augmented tumor therapy: strategies, challenges, and perspectives
@mdpipharma.bsky.social🏆 54 citations! Overcoming the #blood–brain #barrier for #CNS #drug #delivery. This review covers physical, biological & chemical strategies plus nanotech—with pros, cons & future directions.
📌 www.mdpi.com/1999-4923/16...
#BloodBrainBarrier #DrugDelivery #CNS #Nanomedicine
